Early behavioral and developmental interventions in ADNP-syndrome: A case report of SWI/SNF-related

Amelle Shillington1, Ernest Pedapati1, Robert Hopkin1

  • 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Insights

Activity-dependent neuroprotector homeobox gene (ADNP) syndrome, a common cause of autism spectrum disorder (ASD), is detailed in a case report. Antipsychotic medication effectively managed behavioral issues, improving early intervention outcomes.

Area of Science:

  • Genetics
  • Neurodevelopmental Disorders
  • Pediatrics

Background:

  • Autism spectrum disorder (ASD) affects 1 in 59 children, with gene variants like ADNP being a common cause.
  • ADNP syndrome is characterized by ASD and intellectual disability.
  • Syndromic ASD often involves comorbidities and developmental challenges.

Observation:

  • A case report details a 2.5-year-old diagnosed with ADNP syndrome.
  • Key features included ASD, global developmental delay, behavioral issues, heart defects, and vision problems.
  • Congenital diaphragmatic hernia (CDH) was a novel initial presentation for this syndrome.

Findings:

  • Antipsychotic medication led to near-complete resolution of behavioral outbursts.
  • Symptom management facilitated engagement in early intervention therapies.
  • Progress in language acquisition was observed following treatment.

Implications:

  • This report offers guidance on antipsychotic dosing for ADNP syndrome.
  • Effective symptom management can enhance early intervention success.
  • The first reported case of CDH in ADNP syndrome expands the condition's known features.
Abstract

Related Concept Videos